welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
scientific articles
The Successful Use of Recombinant Factor VIIa in a Patient with Vascular-Type Ehlers-Danlos Syndrome
source: Acta Anaesthesiologica Scandinavica
year: 2007
authors: Faber P, Craig WL, Duncan JL, Holliday K
summary/abstract:Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding.
organization: Aberdeen Royal InfirmaryDOI: 10.1111/j.1399-6576.2007.01416.x
read more full text source
expertly curated content related to this topic
-
Titin-based Stiffening of Muscle Fibers in Ehlers-Danlos SyndromeOBJECTIVE: tenascin-X (TNX) is an extra...
-
Morbidity and Mortality after GI-surgery in Ehlers-Danlos Patients: A Systematic ReviewReview question(s): Our aim is to syste...
-
Leslie Russek, PT, DPT, PhD, OCSLeslie Russek, PT, DPT, PhD, OCS, is an ...
-
@JBOccyTherapyEDS is a part of me, A part of my life a...
-
DEFY FoundationThe DEFY Foundation was created in 2014 ...